In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Prime Medicine Inc (NASDAQ: PRME) closed at $1.53 in the last session, down -1.29% from day before closing price of $1.55. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 1.43 million shares were traded.
Ratios:
We take a closer look at PRME’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.78. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.07.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Brudnick Richard bought 20,000 shares for $1.19 per share. The transaction valued at 23,790 led to the insider holds 20,000 shares of the business.
LEE ANN L. bought 100,000 shares of PRME for $113,000 on May 21 ’25. The Chief Technical Officer now owns 100,000 shares after completing the transaction at $1.13 per share. On May 21 ’25, another insider, Reine Allan, who serves as the Chief Executive Officer of the company, bought 125,000 shares for $1.18 each. As a result, the insider paid 147,150 and bolstered with 125,000 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 52.18 while its Price-to-Book (P/B) ratio in mrq is 1.88.
Stock Price History:
Over the past 52 weeks, PRME has reached a high of $8.14, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 7.66%, while the 200-Day Moving Average is calculated to be -44.42%.
Shares Statistics:
A total of 131.16M shares are outstanding, with a floating share count of 51.73M. Insiders hold about 60.60% of the company’s shares, while institutions hold 28.66% stake in the company.
